TrialBioMed research international2014

Clinical outcomes after treatment of periodontal intrabony defects with nanocrystalline hydroxyapatite (Ostim) or enamel matrix derivatives (Emdogain): a randomized controlled clinical trial.

Elyan Al Machot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.